
Organization · Accelerator
BioInnovate Ireland
BioInnovate Ireland is a health technology innovation hub at the University of Galway, established in 2011. It focuses on educating healthcare entrepreneurs through needs-led innovation to enhance patient care globally.
Overview
What BioInnovate Ireland does
What BioInnovate Ireland is
BioInnovate Ireland is a health technology innovation hub at the University of Galway, established in 2011. It focuses on educating healthcare entrepreneurs through needs-led innovation to enhance patient care globally.
How it participates in the startup ecosystem
The current public profile supports program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Program host
- Last reviewed
- May 7, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find BioInnovate Ireland elsewhere
Open the official website or a supported primary organization account.
Capability profile
BioInnovate Ireland as a program host
Program thesis
BioInnovate Ireland is a health technology innovation program aimed at improving patient care through needs-led innovation by bringing together clinicians, engineers, scientists, and business professionals.
Focus narrative
BioInnovate focuses on health technology innovation, specifically in medical devices and digital health. The program supports innovation through three key pillars: the BioInnovate Programme, industry and executive training, and the Ian Quinn Centre for Health Technology Innovation. It targets professionals with diverse backgrounds, including clinical, technical, and commercial fields, particularly those with experience in software, AI, or data analytics.
Value and support
Participants receive a tax-free scholarship of €38,000, and academic fees of up to €5,750 are covered. The program is designed to immerse participants in the clinical innovation journey, from identifying unmet needs to developing solutions and strategies for commercialization.
Terms and economics
- Indicative investment
- $0
- Stipend
- $38,000
Format and cadence
- Typical duration
- 40 weeks
- Format
- In Person
Availability
- Application state
- Not published
- Next deadline
- February 28, 2026
Focus and fit
- Stages
- Accelerator
- Sectors
- Healthcare · Digital Health · Medical Devices
- Regions
- Europe · Global
Alumni and track record
Alumni context
Notable alumni companies include: Perfuze: Specializes in neurovascular devices for treating acute ischemic stroke. Relevium Medical: Focuses on novel pharmacological hydrogel treatments for chronic pain. LUMA Vision: Develops cardiac navigation technology. FeelTect: Innovates in wound care with smart compression monitoring systems.
Connected ecosystem
Continue from BioInnovate Ireland
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about BioInnovate Ireland
Upseed classifies BioInnovate Ireland under the Accelerator organization type. Its current public profile includes program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.